Lavine, Kory J. http://orcid.org/0000-0003-1948-9945
Sultan, Deborah
Luehmann, Hannah
Detering, Lisa
Zhang, Xiaohui
Heo, Gyu Seong
Zhang, Xiuli
Hoelscher, Michelle http://orcid.org/0000-0001-5334-3216
Harrison, Kitty
Combadière, Christophe
Laforest, Richard
Kreisel, Daniel
Woodard, Pamela K.
Brody, Steven L.
Gropler, Robert J.
Liu, Yongjian http://orcid.org/0000-0002-1118-1535
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL161185, HL150891, HL151078, HL145212, HL150891, HL153436, HL151685)
Fondation Leducq (20CVD02)
Burroughs Wellcome Fund (1014782)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (EB025815)
Article History
Received: 18 August 2022
Accepted: 23 August 2023
First Online: 21 September 2023
Competing interests
: K.J.L. serves as a consultant for Implicit Bioscience and Medtronic and is the recipient of sponsored research agreements with Amgen and Novartis. K.J.L., D.K., S.L.B., R.J.G. and Y.L. are inventors on a pending patent entitled ‘Methods for detecting CCR2 receptors’ (application no. US17/001,857). This patent was submitted by Washington University School of Medicine and pertains to the CCR2 imaging tracer used in the manuscript. The other authors declare no competing interests.